On The Pen GLP-1 News
Episodes
Retatrutide Biologic Battle: The Story Gets Bigger
Host Dave Knapp analyzes the Eli Lilly vs.
GLP-1 Showdown: Inside The High Stakes War over Patients
Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know
Host Dave Knapp analyzes new data showing many patients restart GLP-1s after stopping, arguing that systemic barriers like insurance, not patient failure, drive discontinuation.